Literature DB >> 3321988

The risk of having a second retarded child.

H Costeff1, L Weller.   

Abstract

We have studied segregation ratios in 282 Israeli families with normal, nonconsanguineous parents and retarded offspring without specific etiologic diagnosis. Severity of retardation and nature of medical history significantly affected recurrence risk, while sex of propositus and sibs and presence or absence of epilepsy, cerebral palsy, microcephaly, and short stature did not. Segregation rations were 0.095 in cases of severe retardation with normal medical history, 0.216 for mild retardation with normal medical history, 0.230 in cases of all retardation with maternal reproductive inefficiency, and 0.110 for all retardation with other reported prenatal, perinatal, or infantile complications. Estimated recurrence risks in most simplex families dropped sharply with each additional normal child. The recurrence risks are higher than some previously published estimates. Different ascertainment criteria may be responsible for this variation. The criteria used here were compatible with a 3.2% population prevalence of mental retardation with a 0.223 segregation ratio in multiplex sibships. It is recommended that future studies of recurrence risks include similar data permitting evaluation of sensitivity of ascertainment criteria.

Entities:  

Mesh:

Year:  1987        PMID: 3321988     DOI: 10.1002/ajmg.1320270403

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

Review 1.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

2.  Survey of adolescents with severe intellectual handicap.

Authors:  J C Asthana; S Sinha; J S Haslam; H M Kingston
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

Review 3.  Recurrence risks in mental retardation.

Authors:  Y J Crow; J L Tolmie
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.